DelveInsight Business Research

Osteoporosis Market to Accelerate Substantially, Assesses DelveInsight | Key Companies to Look Out For

by

The current therapeutic landscape of osteoporosis in the 7MM is driven by current treatment practices and the expected launch of emerging therapies. The current osteoporosis market witnesses the use of several approved therapies available in different therapeutic classes. LAS VEGAS, June 22, 2023 /PRNewswire/ — DelveInsight’s Osteoporosis Market Insights report includes a comprehensive understanding of current … Read more

Hemophilia Market to Proliferate Immensly, Predicts DelveInsight | Key Companies to Look Out for

by

The current therapeutic landscape of hemophilia in the United States is driven by several approved therapies. The hemophilia market is estimated to grow for the period 2019-2032. The major reason behind the hemophilia market upsurge is the launch of the most anticipated gene therapies, which are considered as a threat to the current hemophilia market. … Read more

Type 2 Diabetes Market to Grow Rapidly, Predicts DelveInsight | Key Companies Active in the Domain

by

The type 2 diabetes market is anticipated to be driven in the coming years due to the rise in novel drugs and therapies and increased healthcare spending across the world. The high prevalence of the disease and the participation of key companies will bring a change in the type 2 diabetes market dynamics LAS VEGAS, … Read more

Alopecia Areata Market to Show Positive Growth at a CAGR of 26.3% During the Study Period (2019-2032), Estimates DelveInsight

by

The alopecia areata market size shall grow during the forecast period owing to the already launched therapies. Moreover, the extensive R&D activities by academics and companies such asConcert Pharmaceuticals, Pfizer, Regeneron Pharmaceuticals, Sanofi, and others shall fuel the growth of the alopecia areata market during the forecast period (2023–2032).  LAS VEGAS, June 19, 2023 /PRNewswire/ … Read more

Parkinson’s Disease Market to Exhibit Growth at a CAGR of 11.2% During the Study Period (2019-2032), Assesses DelveInsight

by

DelveInsight’s analysts estimate that the Parkinson’s disease market is expected to show positive growth, mainly attributed to increased prevalence and the anticipated launch of novel therapies during the forecast period (2023–2032).  LAS VEGAS, May 30, 2023 /PRNewswire/ — DelveInsight’s Parkinson’s Disease Market Insights report includes a comprehensive understanding of current treatment practices, Parkinson’s disease emerging drugs, … Read more

Diabetic Retinopathy Clinical Trial Pipeline Space Brims With Novel Emerging Therapies with Over 50 Key Companies Working in the Domain

by

The prevalence of diabetic retinopathy has been rising over the past few years, which prompts the growing demand for treatment options. The increasing prevalence of diabetic retinopathy and the growing research and development activities to develop novel therapies to treat diabetic retinopathy to drive the market. The companies developing the potential therapies in the last … Read more

Relapsed/Refractory Acute Myeloid Leukemia Market Growing Rapidly, Estimates DelveInsight | Key Companies Active in the Domain

by

DelveInsight’s analysts estimate that relapsed/refractory acute myeloid leukemia market is poised to show significant growth, mainly attributed to recent drug approvals, increasing incidence, and anticipated launch of novel therapies during the forecast period (2023–2032). LAS VEGAS, May 24, 2023 /PRNewswire/ — DelveInsight’s Relapsed/Refractory Acute Myeloid Leukemia Market Insights report includes a comprehensive understanding of current … Read more

Smoking Cessation and Nicotine Addiction Market is Projected to Grow at a CAGR of 2.6% During the Study Period (2019-2032)

by

The smoking cessation and nicotine addiction market is projected to grow positively owing to the increasing R&D activities, healthcare spending, and the expected launch of emerging therapies by leading players such as Achieve Life Sciences, NFL Biosciences SAS, Embera NeuroTherapeutics, Inc, Axsome Therapeutics, and others. LAS VEGAS, May 15, 2023 /PRNewswire/ — DelveInsight’s Smoking Cessation … Read more